Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: A report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study

Yasuhiko Iino, Matsuhiko Hayashi, Tetsuya Kawamura, Tatsuo Shiigai, Yasuhiko Tomino, Kenichi Yamada, Takeyuki Kitajima, Terukuni Ideura, Akio Koyama, Tetsuzo Sugisaki, Hiromichi Suzuki, Satoshi Umemura, Yoshindo Kawaguchi, Shunya Uchida, Michio Kuwahara, Tsutomu Yamazaki

Research output: Contribution to journalArticlepeer-review

19 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: A report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study'. Together they form a unique fingerprint.

Medicine & Life Sciences